Urgent.News

What's breaking now, across thousands of outlets.

Business

Novo is betting on its next chapter as Eli Lilly gains more ground in GLP-1s

As Novo works to turn itself around, some analysts say Lilly has advantages that could help it maintain its position at the top of the obesity drug market.

We haven't written up this one. CNBC has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at cnbc.com →

More in Business

Japan Tops 2026 Travel, Tourism Development Rankings

London, Sept. 25 (Jiji Press)--Japan retook the top spot among 110 economies in the World Economic Forum's 2026 Travel and Tourism Development Index rankings, released on Friday. Japan was followed by the United States in second place, Spain in third, Australia in fourth, and France in fifth, according to the WEF report.

More from Friday 25 September →